Highlights: Raises long-term average annual adjusted EPS1 growth target to 10%-14% Affirms 2024 adjusted EPS1 guidance of at least $28.25 Announces solutions and innovations for some of the greatest health care challenges: GLP-1 spend, mental health care access and support, and access to…